Campana, Mattia http://orcid.org/0000-0003-4596-4287
Löhrs, Lisa
Strauß, Johanna
Münz, Susanne
Oviedo-Salcedo, Tatiana
Fernando, Piyumi
Maurus, Isabel
Raabe, Florian
Moussiopoulou, Joanna
Eichhorn, Peter
Falkai, Peter
Hasan, Alkomiet
Wagner, Elias
Funding for this research was provided by:
Universitätsklinik München
Article History
Received: 10 January 2023
Accepted: 13 February 2023
First Online: 4 March 2023
Declarations
:
: M. Campana, L. Löhrs, J. Strauß, S. Münz, P. Fernando, T. Oviedo-Salcedo, I. Maurus, F. Raabe, J. Moussiopoulou and P. Eichhorn report no conflicts of interest. E. Wagner has been invited to Recordati advisory board meetings. P. Falkai was honorary speaker for Janssen-Cilag, Astra-Zeneca, Eli Lilly, Bristol Myers-Squibb, Lundbeck, Pfizer, Bayer Vital, SmithKline Beecham, Wyeth, and Essex. During the last 5 years, but not presently, he was a member of the advisory boards of Janssen, AstraZeneca, Eli Lilly, and Lundbeck. A. Hasan has been invited to scientific meetings by Lundbeck, Janssen-Cilag, and Pfizer, and he received paid speakerships from Janssen, Recordati, Otsuka and Lundbeck. He was a member of Roche, Otsuka, Lundbeck, Rovi, Recordati and Janssen advisory boards.
: This retrospective study was approved by the university ethics committee (registration number: 18–570).